Long‐term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders

Long‐term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders

Objectives To compare transesophageal echocardiography (TOE) findings after patent foramen ovale (PFO) closure by BioSTAR (NMT Medical Inc, Boston, MA) and Amplatzer PFO occluders (Abbott Vascular, Plymouth, MN). Background PFO closure with a biodegradable device represents an attractive alternative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2020-02, Vol.95 (3), p.349-354
Hauptverfasser: Suligoj, Natasa Cernic, Rojko, Maja, Suligoj, Brina, Zorc, Metka, Kar, Saibal, Noc, Marko
Format: Artikel
Sprache:eng
Schlagworte:
Aneurysms
Biodegradability
Biodegradation
Echocardiography
Effusion
Embolization
Fever
metal frame protrusion
Patients
residual shunt
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To compare transesophageal echocardiography (TOE) findings after patent foramen ovale (PFO) closure by BioSTAR (NMT Medical Inc, Boston, MA) and Amplatzer PFO occluders (Abbott Vascular, Plymouth, MN). Background PFO closure with a biodegradable device represents an attractive alternative to permanent devices. Long‐term effectiveness and morphology after biodegradation remain unknown. Methods Between February 2008 and June 2014, 49 patients received BioSTAR and 48 Amplatzer PFO occluder. TOE was performed after closure, at 6 months and beyond 2 years. Results PFO features were comparable between the groups. Immediate effective closure (
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.28360